Changes in Beneficial Ownership · 4
Journey Medical Corporation
DERMNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
tm2619089-1_4seq1.xml
Filing details
- Report period
- 2026-06-25
- Issuer
- Journey Medical Corp
- Issuer CIK
- 0001867066
- Trading symbol
- DERM
Reporting owner 1
- Name
- ROSENWALD LINDSAY A MD
- Reporting owner CIK
- 0000941841
- Relationship
- Director
- Address
- C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | 2026-06-25 | A · Form 4 | 10,000[F1] | A | 0 | 221,146[F2] | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Stock, $0.0001 par value | 176,470 | I | See Footnote[F3] |
Table key
- I
- Indirect
Footnotes
- F1
- On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027.↩ 1
- F2
- Includes restricted stock units, which vest over various time periods.↩ 1
- F3
- The shares are held by a limited liability company over which the reporting person, as managing member, is deemed to have voting and investment power.↩ 1
Signature 1
- Signed
- /s/ Ramsey Alloush, attorney-in-fact
- Date
- 2026-06-26
Company context
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets nine branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and the company files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.